Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 23, 2021 at 12:52 PM.

  1. #1 cafead, Jul 23, 2021 at 12:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via The FDA has now approved AstraZeneca's convenient once-a-week glucose lowering drug for 10 to 17-year-olds with type 2 diabetes. In a pivotal trial, the Bydureon BCise injection significantly reduced blood sugar in the adolescents receiving the drug, as measured by HbA1c.

    article source
     
    Quote

Reply to Thread